Literature DB >> 25128643

Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion studies of sweroside in rats.

Ning Sheng1, Lin Yuan2, Xuran Zhi3, Cheng Cui3, Zhiyong Zhang2, Peipei Jia2, Xiaoxu Zhang2, Lantong Zhang4, Xinguo Wang5.   

Abstract

A sensitive, reliable and accurate high-performance liquid chromatography with tandem mass spectrometry (HPLC-MS/MS) was developed and validated for the quantification of sweroside in rat plasma, tissue and excretion. A single-step protein precipitation by methanol was used to prepare samples. Sweroside and swertiamarin (internal standard, IS) were separated by using a C18 column and a mobile phase consisted of methanol and water containing 0.1% formic acid running at a flow rate of 0.8ml/min for 6min. Detection and quantification were performed using a mass spectrometer by the multiple-reaction monitoring (MRM) in positive electrospray ionization mode. The optimized mass transition ion pairs (m/z) for quantitation were [M+H](+)359.1→197.2 for sweroside and [M+Na](+)397.4→165.3 for swertiamarin (IS), respectively. The inter-day precision (RSD %) was less than 11.20% and intra-day precision (RSD %) was less than 10.90%, while the inter-day accuracy (RE %) was ranged from -9.69 to 9.17% and intra-day accuracy (RE %) was ranged from -10.56 to 13.47%. The mean elimination half-life (t1/2) of sweroside for 5, 10 and 15mg/kg dose were 78.8, 67.6 and 77.2min, respectively. And sweroside follows linear plasma pharmacokinetics across the investigated dosage range in rats (5-15mg/kg). The absolute bioavailability (F %) of sweroside was 11.90% on average. The results of tissue distribution showed the higher sweroside concentrations were found in kidney, liver, spleen and lung, and the small amount of drug was distributed into the brain tissue. The high distribution in liver confirms the reports that sweroside has hepatoprotective activity and promoted liver regeneration, and there was no long-term accumulation of sweroside in rat tissues. Total recoveries of sweroside within 48h were 0.67% in bile, 1.55% in urine and 0.46% in feces, which might be resulted from liver first-pass effect. The above results suggested that sweroside was mainly excreted as the metabolites.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Excretion study; LC–ESI-MS/MS; Pharmacokinetics; Sweroside; Tissue distribution

Mesh:

Substances:

Year:  2014        PMID: 25128643     DOI: 10.1016/j.jchromb.2014.07.042

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Anticancer 20(R)-dammarane-3β,12β,20,25-tetrol-loaded polymeric micelles: Preparation, quantification and pharmacokinetics.

Authors:  Junxian Yu; Zhe Li; Wei Wang; Yang Zhang; Dandan Li; Yi Liu; Su Shen; Ruiwen Zhang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-04-01       Impact factor: 3.205

2.  Simultaneous Determination of Seven Components in Rat Plasma by the UPLC-MS/MS Method and Application of Pharmacokinetic Studies to SimiaoYong'an Decoction.

Authors:  Yuanyan Liu; Sensen Chi; Weihua Wang; Lei Su; Bin Liu
Journal:  Molecules       Date:  2017-11-09       Impact factor: 4.411

3.  Potential Toxicity Evaluation of Protopine in Macleaya cordata (Willd.) R. Br.-A Bioactivity Guided Approach.

Authors:  Wanjun Hu; Fan Yang; Weixue Liu; Liyang Guo; Liwen Ai; Xiaomeng Zhang; Zunlai Sheng; Chunbo Gao
Journal:  Front Vet Sci       Date:  2021-11-25

4.  Comparative Pharmacokinetics of Seven Major Compounds in Normal and Atherosclerosis Mice after Oral Administration of Simiao Yong'an Decoction.

Authors:  Ke-Han Sun; Man-Fang Yang; Xin-Rui Xu; Yang Li; Zhao Gao; Qing-Yue Zhang; Hui Li; Shu-Qi Wang; Li-Xia Lou; Ai-Ming Wu; Qiu-Shuo Jin; Sheng-Xian Wu; Bo Nie
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-28       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.